Thomas Cheng
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Wnt/β-catenin signaling in development and cancer 2
- Epigenetics and DNA Methylation 2
- Protein Degradation and Inhibitors 1
- Oncology 6
- Cancer Cells and Metastasis 2
- Colorectal Cancer Treatments and Studies 1
- Cancer Treatment and Pharmacology 1
- Co-authors
- Sihan Chen (1 shared paper)David W. C. Yeung (1 shared paper)Khoa Nguyen (7 shared papers)Bridgette M. Collins‐Burow (6 shared papers)Matthew E. Burow (6 shared papers)Sirong Chen (3 shared papers)Raymond Liang (1 shared paper)Chi-Lai Ho (3 shared papers)
- Journals
- Cancers (1 paper)Cancer Research (1 paper)Journal of Nuclear Medicine (1 paper)Biomedicine & Pharmacotherapy (1 paper)
- Partner nations
- United StatesHong KongIran
In The Last Decade
Thomas Cheng
12 papers receiving 276 citations
Peers
Comparison fields: 5 of 51
- Hepatology 97
- Cancer Research 58
- Hematology 38
- Oncology 90
- Radiology, Nuclear Medicine and Imaging 74
Countries citing papers authored by Thomas Cheng
This map shows the geographic impact of Thomas Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cheng more than expected).
Fields of papers citing papers by Thomas Cheng
This network shows the impact of papers produced by Thomas Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cheng. The network helps show where Thomas Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 153 | |
| 2 | 2014 | 41 | |
| 3 | 2021 | 26 | |
| 4 | 2022 | 18 | |
| 5 | 2022 | 13 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 10 | |
| 8 | 2023 | 8 | |
| 9 | Dual-tracer PET/CT for the differential diagnosis of small liver nodules (1-2 cm) in cirrhosis: Early HCC or dysplastic nodule? | 2012 | 1 |
| 10 | 2015 | 1 | |
| 11 | Functional analysis of 18F-DOPA PET for the diagnosis of Parkinson's disease | 2012 | 1 |
| 12 | 2022 | 1 |
About Thomas Cheng
Thomas Cheng is a scholar working on Molecular Biology, Oncology, Hepatology, Cancer Research and Genetics, having authored 12 papers that have together received 285 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cancer Cells and Metastasis (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Cancer Treatment and Pharmacology (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Hepatology (97 citations), Cancer Research (58 citations), Hematology (38 citations), Oncology (90 citations) and Radiology, Nuclear Medicine and Imaging (74 citations). Thomas Cheng has collaborated with scholars based in United States, Hong Kong and Iran. Frequent co-authors include Sihan Chen, David W. C. Yeung, Khoa Nguyen, Bridgette M. Collins‐Burow, Matthew E. Burow, Sirong Chen, Raymond Liang, Chi-Lai Ho, Chor Sang Chim and Hassan Yousefi. Their work appears in journals such as Cancers, Cancer Research, Journal of Nuclear Medicine, Biomedicine & Pharmacotherapy and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.